These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 38812129)
1. [Research progress on mechanisms of ligustilide in treatment of nervous system diseases]. Li XX; Yang P; Zhang YH; Song W; Wang XM; Li J Zhongguo Zhong Yao Za Zhi; 2024 May; 49(9):2290-2298. PubMed ID: 38812129 [TBL] [Abstract][Full Text] [Related]
2. [Research progress studies on pharmacology and pharmacokinetics of ligustilide]. Zuo AH; Wang L; Xiao HB Zhongguo Zhong Yao Za Zhi; 2012 Nov; 37(22):3350-3. PubMed ID: 23373200 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, brain distribution, release and blood-brain barrier transport of Shunaoxin pills. Wu K; Wang ZZ; Liu D; Qi XR J Ethnopharmacol; 2014 Feb; 151(3):1133-1140. PubMed ID: 24373808 [TBL] [Abstract][Full Text] [Related]
4. Z-ligustilide: A review of its pharmacokinetics and pharmacology. Xie Q; Zhang L; Xie L; Zheng Y; Liu K; Tang H; Liao Y; Li X Phytother Res; 2020 Aug; 34(8):1966-1991. PubMed ID: 32135035 [TBL] [Abstract][Full Text] [Related]
5. Factors affecting stability of z-ligustilide in the volatile oil of radix angelicae sinensis and ligusticum chuanxiong and its stability prediction. Cui F; Feng L; Hu J Drug Dev Ind Pharm; 2006 Jul; 32(6):747-55. PubMed ID: 16885129 [TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory ligustilides from Ligusticum chuanxiong Hort. Huang J; Lu XQ; Zhang C; Lu J; Li GY; Lin RC; Wang JH Fitoterapia; 2013 Dec; 91():21-27. PubMed ID: 23973655 [TBL] [Abstract][Full Text] [Related]
7. Identification and comparison of metabolites after oral administration of essential oil of Ligusticum chuanxiong or its major constituent ligustilide in rats. Ding C; Sheng Y; Zhang Y; Zhang J; Du G Planta Med; 2008 Nov; 74(14):1684-92. PubMed ID: 18951338 [TBL] [Abstract][Full Text] [Related]
8. Determination of ligustilide in rat brain after nasal administration of essential oil from Rhizoma Chuanxiong. Guo J; Duan JA; Shang EX; Tang Y; Qian D Fitoterapia; 2009 Apr; 80(3):168-72. PubMed ID: 19535021 [TBL] [Abstract][Full Text] [Related]
9. Relaxation effects of ligustilide and senkyunolide A, two main constituents of Ligusticum chuanxiong, in rat isolated aorta. Chan SS; Cheng TY; Lin G J Ethnopharmacol; 2007 May; 111(3):677-80. PubMed ID: 17222996 [TBL] [Abstract][Full Text] [Related]
10. The influence and mechanism of ligustilide, senkyunolide I, and senkyunolide A on echinacoside transport through MDCK-MDR1 cells as blood-brain barrier in vitro model. Zheng Q; Tang Y; Hu PY; Liu D; Zhang D; Yue P; Guo Y; Yang M Phytother Res; 2018 Mar; 32(3):426-435. PubMed ID: 29193364 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and metabolism of ligustilide, a major bioactive component in Rhizoma Chuanxiong, in the rat. Yan R; Ko NL; Li SL; Tam YK; Lin G Drug Metab Dispos; 2008 Feb; 36(2):400-8. PubMed ID: 18039808 [TBL] [Abstract][Full Text] [Related]
12. Bioactivity-guided fractionation and GC/MS fingerprinting of Angelica sinensis and Angelica archangelica root components for antifungal and mosquito deterrent activity. Wedge DE; Klun JA; Tabanca N; Demirci B; Ozek T; Baser KH; Liu Z; Zhang S; Cantrell CL; Zhang J J Agric Food Chem; 2009 Jan; 57(2):464-70. PubMed ID: 19113871 [TBL] [Abstract][Full Text] [Related]
13. [Comparative Study on Volatile Oil Composition of Chuanxiong Rhizoma, Angelicae Sinensis Radix and Ligustici Rhizoma et Radix]. Yang Y; Yi JH; Huang ZF; Liu YH; Liu YH; Chen Y Zhong Yao Cai; 2015 Jun; 38(6):1212-6. PubMed ID: 26762063 [TBL] [Abstract][Full Text] [Related]
14. A new procedure for the preparative separation and isolation of Z-ligustilide from the roots of Angelica sinensis. Yi T; Zhang H; Xie J; Xue D J Sep Sci; 2007 Aug; 30(12):1973-8. PubMed ID: 17638355 [TBL] [Abstract][Full Text] [Related]
15. Ligustilide reduces phenylephrine induced-aortic tension in vitro but has no effect on systolic pressure in spontaneously hypertensive rats. Du JR; Yu Y; Yao Y; Bai B; Zong X; Lei Y; Wang CY; Qian ZM Am J Chin Med; 2007; 35(3):487-96. PubMed ID: 17597507 [TBL] [Abstract][Full Text] [Related]
16. Ligustilide suppresses the biological properties of Danggui Buxue Tang: a Chinese herbal decoction composed of radix astragali and radix angelica sinensis. Zheng YZ; Choi RC; Li J; Xie HQ; Cheung AW; Duan R; Guo AJ; Zhu JT; Chen VP; Bi CW; Zhu Y; Lau DD; Dong TT; Lau BW; Tsim KW Planta Med; 2010 Mar; 76(5):439-43. PubMed ID: 19847742 [TBL] [Abstract][Full Text] [Related]
17. Ligustilide Ameliorates the Permeability of the Blood-Brain Barrier Model In Vitro During Oxygen-Glucose Deprivation Injury Through HIF/VEGF Pathway. Wu S; Wang N; Li J; Wang G; Seto SW; Chang D; Liang H J Cardiovasc Pharmacol; 2019 May; 73(5):316-325. PubMed ID: 30855407 [TBL] [Abstract][Full Text] [Related]
18. Ligustilide improves aging-induced memory deficit by regulating mitochondrial related inflammation in SAMP8 mice. Zhu WL; Zheng JY; Cai WW; Dai Z; Li BY; Xu TT; Liu HF; Liu XQ; Wei SF; Luo Y; Wang H; Pan HF; Wang Q; Zhang SJ Aging (Albany NY); 2020 Feb; 12(4):3175-3189. PubMed ID: 32065782 [TBL] [Abstract][Full Text] [Related]
19. [The new progress of the study about volatile oil of the angelica]. Du JR; Bai B; Yu Y; Wang CY; Qian ZM Zhongguo Zhong Yao Za Zhi; 2005 Sep; 30(18):1400-6. PubMed ID: 16381456 [TBL] [Abstract][Full Text] [Related]
20. Intranasal Pretreatment with Z-Ligustilide, the Main Volatile Component of Rhizoma Chuanxiong, Confers Prophylaxis against Cerebral Ischemia via Nrf2 and HSP70 Signaling Pathways. Li J; Yu J; Ma H; Yang N; Li L; Zheng DD; Wu MX; Zhao ZL; Qi HY J Agric Food Chem; 2017 Mar; 65(8):1533-1542. PubMed ID: 28169530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]